Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Astrin Biosciences has developed a patented platform that uses deep learning and advanced imaging to analyze individual circulating tumor cells from blood samples. This enables highly sensitive early detection of cancer, real-time monitoring of treatment response, discovery of novel therapeutic targets, and identification of resistance mechanisms. The company has presented promising research results in metastatic prostate, liver, and pancreatic cancers in collaboration with leading academic centers such as Memorial Sloan Kettering Cancer Center[2][7].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Astrin Biosciences.